By the Top Tier Newswire AI Desk · September 29, 2026 at 12:22 PM ET · reviewed against 4 wire stories
REPLIMUNE GROUP INC (REPL) is up +6.37% in the latest session. Our newswire has captured 4 stories on REPL across 1 source in the last 36 hours, with AI sentiment reading bearish (avg 40/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
REPLIMUNE GROUP INC stock rose 6.37% to $13.36 in morning trading on Sept. 29, 2026, driven by a surge in investor interest amid multiple class action alerts and a recent capital-raising effort. The stock opened at $12.59 and climbed to an intraday high of $13.39 before settling near the high at $13.36. The move occurred as four separate class action notices were issued within 36 hours, each urging shareholders to consider legal action.
What Happened
Four law firms issued class action alerts on behalf of Replimune Group, Inc. investors within a 36-hour period. The Portnoy Law Firm, Bronstein, Gewirtz & Grossman LLC, the Law Offices of Frank R. Cruz, and Levi & Korsinsky each announced separate lawsuits alleging investor harm and urging shareholders to evaluate their options. These alerts typically increase short-term trading activity as investors assess their legal exposure and potential for recovery. The Portnoy Law Firm set a lead plaintiff deadline of October 5, 2026, while others referenced similar claims. The timing of these alerts coincided with a broader period of market volatility and increased attention to the company's capital-raising moves.
What The Data Shows
The stock traded on a volume of 1.1 million shares, or 0.2 times the 3-month daily average, indicating elevated but not extreme liquidity. The price trend over the last 8 sessions showed a decline of 5.2% from $13.17 to $12.49, making the current rise notable against a recent downward trend. The stock closed at $13.36, just below its 52-week high of $16.33 and well above its 52-week low of $1.50. On the same day, the stock also printed one fresh 52-week low and 17 fresh 52-week highs, reflecting mixed retail and institutional sentiment. Recent insider transactions included five sales totaling $1.0 million, with the most recent occurring on August 19. The CEO and CFO both sold shares in early August.
What To Watch
Investors should monitor the lead plaintiff deadline of October 5, 2026, and any developments in the class action lawsuits. Additionally, coverage breadth and further capital-raising activity will be key indicators of the company’s near-term direction.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
REPL · today's session (5-min) · +3.50% vs prior close · updated 4:53 PM ETAI sentiment, last 36h · averaged over 4 stories · 40/100 bearish
The headlines behind the move
Story flow · 4 stories on the wire, last 36h · hover or tap a dot for the headline
4h agoGlobeNewswireNEUTRAL 50General
DEADLINE ALERT for REPL, DVLT, and UWMC: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
LOS ANGELES, Sept. 29, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf...
8h agoGlobeNewswireBEARISH 42General
Portnoy Law Firm Announces Class Action on Behalf of Replimune Group, Inc. Investors
LOS ANGELES, Sept. 29, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Replimune Group, Inc., (“Replimune” or the
1d agoGlobeNewswireBEARISH 34General
Bronstein, Gewirtz & Grossman LLC Urges Replimune Group, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
New class action for Replimune (REPL) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 10/5/2026...
1d agoGlobeNewswireBEARISH 34General
REPL Investor Alert: Replimune Group, Inc. Securities Class Action Notice - Contact Levi & Korsinsky
Institutional holders of Replimune Group, Inc. (NASDAQ: REPL) may wish to evaluate lead plaintiff options in a securities class action alleging the Company...
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →